missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. 18415274

Annexin A7 Antibody (OTI1C3), DyLight 594, Novus Biologicals™

Product Code. 18415274 Shop All Bio Techne Products
Change view
Click to view available options
Quantity:
0.1 mL
Unit Size:
0.1mL
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Product Code. Quantity unitSize
18415274 0.1 mL 0.1mL
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
This item is not returnable. View return policy
Product Code. 18415274 Supplier Novus Biologicals Supplier No. NBP270181DL594

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Mouse Monoclonal Antibody

Annexin A7 Monoclonal antibody specifically detects Annexin A7 in Human, Mouse, Rat samples. It is validated for Western Blot
TRUSTED_SUSTAINABILITY

Specifications

Antigen Annexin A7
Applications Western Blot
Classification Monoclonal
Clone OTI1C3
Conjugate DyLight 594
Formulation 50mM Sodium Borate
Gene Alias annexin A7, ANX7, ANXA7, SNX, SYNEXIN
Host Species Mouse
Immunogen Recombinant protein fragment corresponding to amino acids 105-411 of human Annexin A7 (NP_004025) produced in E.coli.
Purification Method Immunogen affinity purified
Quantity 0.1 mL
Regulatory Status RUO
Research Discipline Cancer
Primary or Secondary Primary
Gene ID (Entrez) 310
Target Species Human, Mouse, Rat
Content And Storage Store at 4°C in the dark.
Form Purified
Isotype IgG1
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.